Armata Pharmaceuticals, Inc. Common Stock (ARMP)
R&D Expense Growth
24.14%
Quarterly · Period ending:
ARMP R&D Expense Growth
Latest reported24.14%period ending
Latest reported24.14%period ending
ARMP Quarterly R&D Growth (QoQ) (0.00% → 24.14%)
Latest values, visible window
High-resolution chart · PNG
ARMP r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 24.1368% | |
| 0.6755% | |
| 4.2239% | |
| -8.9146% | |
| 17.7749% | |
| -35.7515% | |
| -10.912% | |
| 11.9174% | |
| 5.726% | |
| 1.11% | |
| -0.6267% | |
| -3.4023% | |
| -14.0046% | |
| 0.3658% | |
| 13.9167% | |
| -6.8736% | |
| 12.3568% | |
| 66.7636% | |
| -14.433% | |
| 7.6746% | |
| 20.1149% | |
| -12.6506% | |
| 22.4791% | |
| 53.5498% | |
| -3.7091% | |
| 64.8681% | |
| -44.7499% | |
| -1.8531% | |
| 105.8902% | |
| 8.6545% | |
| 280.8864% | |
| -78.6643% | |
| 15.5738% | |
| 34.3119% | |
| 231.4837% | |
| -173.3628% | |
| -24.1611% | |
| 85.7855% | |
| -51.5408% | |
| 33.3602% | |
| -37.3232% | |
| 62.963% | |
| 66.8956% | |
| -32.4048% | |
| 10.8025% | |
| -13.059% | |
| -38.0266% | |
| -3.838% | |
| 86.4811% | |
| -11.986% | |
| 1.7809% | |
| -68.7622% | |
| 460.8424% | |
| 0% | |
| -19.8837% | |
| -10.8019% | |
| -45.4873% | |
| 21.8358% | |
| -23.1954% | |
| 5.3218% | |
| -18.9567% | |
| 25.684% | |
| -26.4896% | |
| 42.5866% | |
| -7.5769% | |
| 28.05% | |
| -15.205% | |
| 0.1632% | |
| -12.4315% | |
| -9.7571% | |
| -3.2238% | |
| 5.9264% | |
| 14.7661% | |
| -7.3336% | |
| -11.599% | |
| 13.9485% | |
| -3.2869% | |
| 10.9957% | |
| -8.7821% | |
| -4.7336% | |
| -27.5251% | |
| -18.4409% | |
| -7.6997% | |
| -7.8991% | |
| -6.0004% | |
| 8.0571% | |
| 34.0615% | |
| 3.8323% | |
| -2.4118% | |
| 45.4162% | |
| -0.7272% | |
| 22.0549% | |
| -7.05% | |
| 11.1111% | |
| 2.8571% | |
| 9.375% | |
| -30.4348% | |
| 58.6207% | |
| 11.5385% | |
| -18.75% |